Such an approach may be particularly relevant when targeting STn-expressing tumors, as STn expression is frequently associated with tumor invasiveness, metastasis and immune escape, especially in breast and bladder cancer [17, 39–41]. This evidence concerns the gene EEF1A2 and urinary bladder cancer.